Form 8-K - Current report:
SEC Accession No. 0001493152-21-003373
Filing Date
2021-02-11
Accepted
2021-02-11 16:01:59
Documents
6
Period of Report
2021-02-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 45856
2 ex4-1.htm EX-4.1 118097
3 ex5-1.htm EX-5.1 14811
4 ex10-1.htm EX-10.1 262652
5 ex10-2.htm EX-10.2 146086
6 ex99-1.htm EX-99.1 16269
  Complete submission text file 0001493152-21-003373.txt   605182
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 21619515
SIC: 3674 Semiconductors & Related Devices